Dr. Timothy James Blair, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 701 Broad Street, Suite 2, Keosauqua, IA 52565 Phone: 319-293-7771 Fax: 866-894-9687 |
Dr. Richard Dale Breckenridge, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 304 Franklin St, Keosauqua, IA 52565 Phone: 319-293-3171 Fax: 319-293-3473 |
Dr. Matthew Arthur Manning, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 304 Franklin St, Keosauqua, IA 52565 Phone: 319-293-3171 Fax: 319-293-3473 |
Dr. Rebecca Bollin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 304 Franklin St, Keosauqua, IA 52565 Phone: 319-293-3171 Fax: 319-293-3473 |
News Archive
A survey of nurses and physicians in intensive care units (ICUs) in Europe and Israel indicated that the perception of inappropriate care, such as excess intensity of care for a patient, was common, and that these perceptions were associated with inadequate decision sharing, communication and job autonomy, according to a study in the December 28 issue of JAMA.
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, has introduced a new version of its SIMCA and SIMCA-online data analytical solutions, which are offered by its subsidiary Sartorius Stedim Data Analytics, formerly known as Umetrics.
Seaweed could hold the key to tackling obesity after it was found it reduces fat uptake by more than 75 per cent, new research has shown.
Stereotypes about who will use online support groups are wrong, according to research at the University of Wisconsin-Madison. The researchers found that age, income and education did not predict participation, although minorities were not as active as other users.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
› Verified 3 days ago